Bezafibrate improves postprandial hypertriglyceridemia and associated endothelial dysfunction in patients with metabolic syndrome: a randomized crossover study

Simvastatin and bezafibrate increase cholesterol efflux in men with type 2 diabetes

(2013) Michela Triolo et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Postprandial lipoproteins and the molecular regulation of vascular homeostasis

(2013) Kathleen M. Botham et al.   PROGRESS IN LIPID RESEARCH

Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction

(2012) Alexander Tenenbaum et al.   Cardiovascular Diabetology

Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?

(2012) Alexander Tenenbaum et al.   Cardiovascular Diabetology

Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT study

(2012) Tamio Teramoto et al.   Cardiovascular Diabetology

The Controversies of Statin Therapy

(2012) J. Wouter Jukema et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiovascular Events in Patients Received Combined Fibrate/Statin Treatment versus Statin Monotherapy: Acute Coronary Syndrome Israeli Surveys Data

(2012) Alexander Tenenbaum et al.   PLoS One

Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction

(2011) Kei Yunoki et al.   ATHEROSCLEROSIS

Fenofibrate Reduces Postprandial Hypertriglyceridemia in CD36 Knockout Mice

(2011) José C. Sandoval et al.   Journal of Atherosclerosis and Thrombosis

Effect of Bezafibrate on Monocyte Cytokine Release and Systemic Inflammation in Patients With Impaired Fasting Glucose

(2010) Robert Krysiak et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Relation of Clinical Benefit of Raising High-Density Lipoprotein Cholesterol to Serum Levels of Low-Density Lipoprotein Cholesterol in Patients With Coronary Heart Disease (from the Bezafibrate Infarction Prevention Trial)

(2008) Ilan Goldenberg et al.   AMERICAN JOURNAL OF CARDIOLOGY

The Effects of Low-Dose Simvastatin and Ezetimibe Compared to High-Dose Simvastatin Alone on Post-Fat Load Endothelial Function in Patients With Metabolic Syndrome: A Randomized Double-Blind Crossover Trial

(2008) Jobien K Olijhoek et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure

(2007) Satoshi Suzuki et al.   AMERICAN HEART JOURNAL